Huadong Pharmaceutical announced that the import registration application for Primelase, a semiconductor laser therapy device for the three types of medical devices declared by High Technology Products, S.L.U., a wholly-owned subsidiary of the company, was accepted by the State Drug Administration. This product contains 7 treatment heads, which can be used for hair removal and treatment of benign skin and vascular diseases, and has been approved for sale in many countries and regions around the world. This acceptance will not have a significant impact on the company's recent business performance. The product still needs to pass a technical review and obtain a registration certificate before it can be manufactured and sold domestically. There is uncertainty about the review and approval results and timing.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.